CDX
Cancer Types | List of Cell Lines | Cancer Types | List of Cell Lines |
Acute Promyelocytic Leukemia(APL) | HL-60 | Carcinoma; Hepatocellular | Hep G2 |
Acute Lymphoblastic Leukemia(ALL) | MOLT-4 | Adult Hepatocellular Carcinoma | Huh-7 |
Acute Lymphoblastic Leukemia(ALL) | NALM-6 | Carcinoma; Hepatocellular | HEP3B |
Acute Lymphoblastic Leukemia(ALL) | SUP-B15 | Liver Adenocarcinoma | SK-Hep-1 |
Acute Lymphoblastic Leukemia(ALL) | CCRF-CEM | Adenocarcinoma; Renal Cell | ACHN |
Childhood T Acute Lymphoblastic Leukemia(ALL) | Jurkat | Adenocarcinoma; Renal Cell | 786-O |
Chronic Lymphocytic Leukemia(CLL) | Hs 505.T | Gastric Carcinoma | Hs 746T |
Acute Myeloid Leukemia(AML) | MOLM-13 | Gastric Adenosquamous Carcinoma | MKN45 |
Acute Myeloid Leukemia(AML) | OCI-AML-3 | Gastric Carcinoma | NCI-N87 |
Acute Monocytic Leukemia(AML) | THP-1 | Gastric Human papillomavirus-related endocervical adenocarcinoma | SGC-7901 |
Chronic Myelogenous Leukemia (CML) | K-562 | Gastric Carcinoma | SNU-16 |
Biphenotypic B Myelomonocytic Leukemia | MV-4-11 | Gastric Carcinoma | KATO III |
Erythroleukemia | TF-1 | Gastric Signet ring cell carcinoma | NUGC-4 |
Sezary Syndrome | HuT 78 | Gastric Carcinoma | SNU-5 |
Histiocytic Lymphoma | U-937 | Pancreatic Adenocarcinoma | AsPC-1 |
Malignant Non Hodgkins Lymphoma | NK-92 | Pancreatic Adenocarcinoma | BxPC-3 |
Lymphoma | JeKo-1 | Pancreatic Adenocarcinoma | Capan-1 |
Burkitts Lymphoma | Daudi | Pancreatic Ductal Adenocarcinoma; Cystic Fibrosis | CFPAC-1 |
Burkitts Lymphoma American | Ramos | Pancreatic Adenocarcinoma | HPAC |
Lymphoma; Mantle Cell | JVM-2 | Pancreatic Carcinoma | MIA PaCa-2 |
Human Non-Hodgkin's Ki-positive Large Cell Lymphoma | Karpas-299 | Pancreatic Epithelioid Carcinoma | PANC-1 |
Burkitts Lymphoma | Raji | Pancreatic Adenocarcinoma | SW 1990 |
Diffuse Large B-cell Lymphoma Germinal Center B-cell Type | SU-DHL-10 | Pancreatic Adenocarcinoma | Capan-2 |
B-cell non-Hodgkin Lymphoma | SU-DHL-16 | Pancreatic Adenocarcinoma | HEC-1-A |
Diffuse Large B-cell Lymphoma Activated | U-2932 | Small Intestine Adenocarcinoma | HuTu 80 |
Diffuse Large B-cell Lymphoma | DOHH2 | Adenocarcinoma; Colorectal; Dukes' type C, grade IV | SW48 |
Immunoglobulin A Lambda Myeloma | MM.1S | Adenocarcinoma; Colorectal; Dukes' type B | SW480 |
Multiple Myeloma | MM.1R | Adenocarcinoma; Colorectal; Dukes' type C | SW620 |
Multiple Myeloma | MOLP-8 | Adenocarcinoma; Colorectal; Dukes' type C, grade III | SW948 |
Plasma Cell Myeloma | NCI-H929 | Carcinoma; Colorectal | RKO |
Myeloma; Plasmacytoma | RPMI 8226 | Carcinoma; Colorectal | T84 |
Myeloma; Plasmacytoma | U-266 | Carcinoma; Colorectal | HCT 116 |
Fibrosarcoma | HT-1080 | Adenocarcinoma; Colorectal | HT-29 |
Osteosarcoma | SJSA-1 | Adenocarcinoma; Colorectal | HT-55 |
Chondrosarcoma | SW 1353 | Adenocarcinoma; Colorectal; Dukes' type B | LS 174T |
Melanoma | COLO 829 | Carcinoma; Colorectal; Dukes' type C | LS1034 |
Amelanotic Melanoma | A2058 | Adenocarcinoma; Colorectal; Dukes' type C | DLD-1 |
Malignant Melanoma | A-375 | Adenocarcinoma; Colorectal; Dukes' type C, Grade IV | LoVo |
Malignant Melanoma | SK-MEL-28 | Adenocarcinoma; Colorectal; Dukes' type D | COLO 205 |
Malignant Melanoma | SK-MEL-5 | Colon Adenocarcinoma | COLO 320 |
Epidermoid Carcinoma | A-431 | Urinary Bladder Carcinoma | HT-1376 |
Human Glioblastoma Astrocytoma | U-251 MG | Urinary Bladder Transitional Cell Papilloma | RT112/84 |
Likely Glioblastoma | U-87 MG | Urinary Bladder Transitional Cell Papilloma | RT4 |
Glioblastoma | A172 | Urinary Bladder Transitional Cell Carcinoma | UM-UC-3 |
Glioblastoma Multiforme | T98G | Urinary Bladder Transitional Cell Carcinoma | T24 |
Glioblastoma | LN229 | Breast Carcinoma | BT-20 |
Neuroblastoma | IMR-32 | Breast Carcinoma | Hs 578T |
Neuroblastoma | SK-N-BE(2) | Breast Carcinoma | JIMT-1 |
Tongue Squamous Cell Carcinoma | CAL 27 | Breast Carcinoma; Metastatic | MDA-MB-453 |
Pharynx Squamous Cell Carcinoma | FaDu | Breast Carcinoma; Skin | DU4475 |
Esophageal Barrett Adenocarcinoma | OE33 | Breast Adenocarcinoma | MCF7 |
Esophageal Squamous Cell Carcinoma | KYSE-150 | Breast Adenocarcinoma | MDA-MB-231 |
Carcinoma; Epidermoid | A-253 | Breast Adenocarcinoma | MDA-MB-436 |
Lung Carcinoma | NCI-H69 | Breast Adenocarcinoma | MDA-MB-468 |
Lung Carcinoma | NCI-H82 | Breast Adenocarcinoma | SK-BR-3 |
Lung Carcinoma | NCI-H209 | Breast Ductal Carcinoma | BT-474 |
Lung Carcinoma | NCI-H446 | Breast Ductal Carcinoma | BT-549 |
Lung Carcinoma | NCI-H460 | Breast Ductal Carcinoma | MDA-MB-175-VII |
Lung Carcinoma | NCl-H520 | Breast Ductal Carcinoma | T-47D |
Lung Carcinoma | A549 | Breast Ductal Carcinoma | ZR-75-1 |
Lung Carcinoma | DMS 53 | Breast Acantholytic Squamous Cell Carcinoma; TNM Stage IIB, grade 2 | HCC1806 |
Lung Carcinoma | SHP-77 | Breast Ductal Carcinoma; TNM stage IIIA, grade 3 | HCC70 |
Lung Carcinoma | PC-9 | Breast Ductal Carcinoma; TNM stage IIIA, grade 3 | HCC-1419 |
Lung Carcinoma; Anaplastic | Calu-6 | Breast Ductal Carcinoma; TNM Stage IIB, grade 3 | HCC1937 |
Lung Carcinoma; Mucoepidermoid Pulmonary | NCI-H292 | Breast Ductal Carcinoma; TNM Stage IIA, grade 3 | HCC1954 |
Lung Carcinoma; Non-small Cell Lung Cancer | NCI-H1299 | Breast Metaplastic Carcinoma; TNM Stage IV, grade 3 | HCC1569 |
Lung Adenocarcinoma | Calu-3 | Ovarian Adenocarcinoma | OVCAR-3 |
Lung Adenocarcinoma | HCC827 | Ovarian Adenocarcinoma | SK-OV-3 |
Lung Adenocarcinoma; Bronchoalveolar Carcinoma; Stage 3B | NCI-H1650 | Ovarian Endometrioid Adenocarcinoma | TOV-112D |
Lung Adenocarcinoma; Bronchoalveolar Carcinoma | NCI-H1666 | Ovarian Primary Malignant Adenocarcinoma; Clear Cell Carcinoma | TOV-21G |
Lung Adenocarcinoma; Papillary | NCI-H441 | Ovarian Teratocarcinoma | PA-1 |
Bronchioalveolar Carcinoma; Non-small Cell Lung Cancer | NCI-H358 | Ovarian Clear Cell Carcinoma | ES-2 |
Lung Adenocarcinoma; Non-small Cell Lung Cancer; Stage 3B | NCI-H838 | Prostate Carcinoma | 22Rv1 |
Lung Adenocarcinoma; Non-small Cell Lung Cancer | NCI-H1568 | Prostate Carcinoma | LNCaP |
Lung Adenocarcinoma; Non-small Cell Lung Cancer; Stage 4 | NCI-H1755 | Adenocarcinoma; Grade IV | PC-3 |
Lung Adenocarcinoma; Non-small Cell Lung Cancer | NCI-H1975 | Prostate Carcinoma | LNCaP C4-2B |
Lung Adenocarcinoma; Non-small Cell Lung Cancer | NCI-H2228 | Prostate Carcinoma | DU 145 |
Lung Adenocarcinoma; Non-small Cell Lung Cancer; Stage 4 | NCI-H2122 | ||
Non-small Cell Lung Cancer; Squamous Cell | NCI-H1703 | ||
Carcinoma; Small Cell Lung Cancer; Stage E | NCI-H526 | ||
Squamous Cell Lung Carcinoma; Mesothelioma | NCI-H226 | ||
Squamous Cell Lung Carcinoma; Mesothelioma | NCI-H226 | ||
Squamous Cell Lung Carcinom | EBC-1 | ||
Squamous Cell Lung Carcinoma | SK-MES-1 | ||
Lung Atypical Carcinoid | NCI-H727 |